Solarvest Announces Successful Technology Transfer and Commercial Production Scale Up
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/25/16 -- SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest" or the "Company"), wishes to announce that it has successfully transferred the technology governing the process monitoring/testing and protocols of its culture production of its organic Omega-3 product, to its German contract manufacture facilities - confirming commercial production with a representative 2,000 liter batch.
Solarvest''s technical team traveled to Germany to successfully complete the transfer of the Company''s unique organic, vegan Omega-3 fatty acid product. The team, in conjunction with, the contract producer''s process development employees cultured the product to commercially viable volumes and quality. The scale up process was also able to achieve an increase in production yield due to the configuration of the larger equipment. The product was run through various downstream processing options that determined the final bulk product appearance and process. The Company has USA FDA approval, so Solarvest''s next step is to commit to full scale production of saleable product.
Solarvest''s algae-based process produces Omega-3 fatty acid products in a clean, controlled, vegan and certified organic culture system that avoids the environmental pollutants and toxins present in the world''s oceans. The product reduces pressure on ocean fisheries that currently supply the bulk of the nutraceutical and food enhancement Omega-3 market with a sustainable and manageable supply process. The product''s premium differentiation is based on this improved quality and chemical free processing.
About Solarvest BioEnergy Inc.:
Solarvest is an algae technology company that owns numerous key patents and whose algal-based production platform provides it with an extremely flexible production system. The Company''s wholly owned subsidiary, Solarvest PEI, has developed a patented (pending) process to produce the world''s first organic Omega-3 using algae, to help meet the 13 billion dollar global Omega-3 market. The Solarvest system utilizes a natural process growing the algae under closely controlled conditions ensuring that the health product(s) produced have none of the environmental contaminants found in our oceans. Organic certification provides assurance that the product(s) is GMO free, sustainable, produced without chemicals and, being algae, supports vegetarian and vegan diets. Solarvest''s licensed Organic Omega-3 products will offer the consumer a healthy and sustainable product choice.
The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from Solarvest''s expectations and projections.
Contacts:
Solarvest BioEnergy Inc.
Gerri Greenham
Chief Executive Officer
416 420 0947
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.01.2016 - 07:30 Uhr
Sprache: Deutsch
News-ID 1410831
Anzahl Zeichen: 3724
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Alternative Energy
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 111 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Solarvest Announces Successful Technology Transfer and Commercial Production Scale Up
"
steht unter der journalistisch-redaktionellen Verantwortung von
Solarvest BioEnergy Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
